Clinical profiles of four patients who died after developing drug-induced hepatitis
| Sex | Age yrs | Onset of hepatitis weeks | HBsAg | HCVAb | Drinking history | Predominant hepatotoxic drugs# | Symptoms¶ | ALT¶ U·L−1 | Bilirulin¶ µmol·L−1 |
| Male+ | 69 | 6 | + | NA | NA | H, R, Z | NA | 149 | Normal |
| Female | 91 | 8.4 | NA | NA | NA | H, R | NA | 27 | 55 |
| Male | 67 | 17.3 | + | NA | NA | H, R, Z | Tiredness | 761 | 73 |
| Male | 75 | 27 | NA | NA | NA | H, R | No | 750 | 162 |
HBsAg: hepatitis B surface antigen; HCVAb: hepatitis C antibody; ALT: alanine aminotransferase; NA: not available; H: isoniazid; R: rifampicin; Z: pyrazinamide. #: within the previous 4 weeks; ¶: at the time of diagnosis; +: overdosed with pyrazinamide 3,500 mg·day−1.